Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Pharmaceuticals, Inc. receives ANDA approval for Bupropion Hydrochloride Extended-Release Tablets
03-02-2022

USFDA issues 3 minor observations to Granules India arm in pre-approval inspection

Granules Pharmaceuticals located in Chantilly, Virginia, US, had undergone a PAI by the US Food and Drug Administration (USFDA) from January 24-28, 2022, the company said in a statement.
31-01-2022
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Pharmaceuticals, Inc. concludes US FDA Audit with Three Minor Observations
31-01-2022

Granules India gets USFDA nod for generic product

The US Food Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Potassium Chloride for Oral Solution filed by Granules Pharmaceuticals Inc (GPI), a wholly-owned foreign subsidiary of the company.
28-01-2022
Bigul

GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Pharmaceuticals, Inc. Receives ANDA Approval for Potassium Chloride for Oral Solution USP, 20 mEq
28-01-2022
Bigul

GRANULES INDIA LTD.-$ - 532482 - Board Meeting Intimation for To Consider And Approve The Un-Audited Financial Results For The Third Quarter Ended December 31, 2021 And The Payment Of Third Interim Dividend For The FY 2021-22, If Any.

GRANULES INDIA LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2022 ,inter alia, to consider and approve To consider and approve the Un-audited Financial Results for the third quarter ended December 31, 2021 and the payment of third interim dividend for the FY 2021-22, if any.
27-01-2022
Bigul

GRANULES INDIA LTD.-$ - 532482 - Newspaper Advertisement Confirming Dispatch Of Postal Ballot Notice.

Newspaper advertisement confirming dispatch of Postal Ballot Notice.
25-01-2022
Bigul

GRANULES INDIA LTD.-$ - 532482 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for FMR LLC & FIL Ltd
21-01-2022
Bigul

GRANULES INDIA LTD.-$ - 532482 - Statement Of Investor Complaints For The Quarter Ended December 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- CHAITANYA TUMMALADesignation :- Company Secretary and Compliance Officer
07-01-2022
Next Page
Close

Let's Open Free Demat Account